A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in patients with specific genetic mutations. The research, involving over ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!

Share on Pinterest New research suggests an anti-inflammatory diet may improve outcomes for people with stage 3 colon cancer. GMVozd/Getty Images An anti-inflammatory diet may be beneficial for colon ...

Colorectal cancer is one of the leading causes of cancer-related deaths in the United States, and as the years pass, it’s clear that the degree of people under 50 that are being diagnosed with the ...

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

Can exercise “therapy” and diet improve survival in patients with colon cancer? It appears so, according to two pivotal studies presented at American Society of Clinical Oncology (ASCO) 2025 annual ...

Colorectal cancer, more popularly known as colon cancer, is one of the most common types of cancer in both men and women around the world. It’s a type of cancer that develops in the tissues of the ...